HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MEF2A gene mutations and susceptibility to coronary artery disease in the Chinese population.

Abstract
We investigated mutations and polymorphisms of the coronary artery disease (CAD)-related myocyte enhancer factor 2A (MEF2A) gene in a Chinese population. Polymerase chain reaction-single-strand conformation polymorphism and DNA sequencing were used to detect exon 11 of the MEF2A gene in 210 Hubei patients with CAD and 190 healthy controls. The following mutations were identified: a) a synonymous heterozygous mutation (147191G→T) combined with a 6-base deletion (147123-147128); b) a synonymous heterozygous or homozygous mutation (147191G→T) combined with a 9-base deletion (147123-147131); c) a synonymous mutation (147143G→A); d) a synonymous mutation (147191G→T) combined with an 18-base deletion (147111-147128); and e) a 21-base deletion (147108-147128). Mutations (a) and (b) and a 3-base deletion (147126-147128) with or without the synonymous heterozygous mutation (147191G→T) occurred in more than 1% of controls. However, mutations (c), (d), and (e) were not observed in the control group. The polymorphism in exon 11 of the MEF2A gene was observed in the Chinese population. Six or seven amino acid deletions and synonymous mutations (147143G→A) may be correlated with susceptibility to CAD.
AuthorsJ Li, H-X Chen, J-G Yang, W Li, R Du, L Tian
JournalGenetics and molecular research : GMR (Genet Mol Res) Vol. 13 Issue 4 Pg. 8396-402 (Oct 20 2014) ISSN: 1676-5680 [Electronic] Brazil
PMID25366733 (Publication Type: Journal Article)
Chemical References
  • MEF2 Transcription Factors
Topics
  • Adult
  • Aged
  • Asian People (genetics)
  • China
  • Coronary Artery Disease (genetics)
  • DNA Mutational Analysis
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • MEF2 Transcription Factors (genetics)
  • Male
  • Middle Aged
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: